Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Enliven Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ELVN
Nasdaq
2834
www.enliventherapeutics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Enliven Therapeutics, Inc.
Enliven Therapeutics Stock In Focus After Wider Loss And FDA Trial Alignment
- Nov 7th, 2026 9:13 am
Enliven Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Business Update
- Nov 5th, 2026 2:05 pm
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
- Oct 14th, 2026 2:30 pm
Why Enliven Therapeutics' (ELVN) ENABLE-2 Trial Design Raises New Questions About Its CML Strategy
- Oct 9th, 2026 10:20 pm
Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial
- Oct 7th, 2026 9:21 am
Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia
- Oct 6th, 2026 2:05 pm
Enliven Therapeutics to Present at Upcoming Investor Conferences
- Sep 3rd, 2026 2:05 pm
Miners And More Lead Slew Of Stocks To Watch — With This Line In Focus
- Sep 2nd, 2026 2:00 pm
Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
- Aug 31st, 2026 4:05 pm
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update
- Aug 5th, 2026 2:05 pm
Profitable Biotechs Strut Their Stuff As Stock Market Stumbles
- Jul 17th, 2026 11:38 am
Enliven Therapeutics (ELVN) Stock Looks Overvalued As Returns Surge But Book Value Lags
- Jul 4th, 2026 12:10 am
What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130%
- Jun 27th, 2026 1:56 pm
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally
- Jun 27th, 2026 10:23 am
Medical Hedge Fund Sells 281,000 Shares of Enliven Theapeutics. Is it Time to Sell ELVN?
- Jun 24th, 2026 1:32 pm
Scroll